HUMAN PAPILLOMA VIRUS QUADRIVALENT VACCINE
Indian Air Force · Healthcare Services · open
Key facts
- Published: 29 Jul 2026
- Closing date: 08 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of Human Papilloma Virus Quadrivalent Vaccine (0.5ml, Types 6, 11, 16 & 18) under the Department of Military Affairs, Indian Air Force, Ministry of Defence. Quantity: 30 units. Bid validity: 90 days from end date. No EMD or ePBG required. Evaluation based on value. No technical clarifications or inspection required.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience/Turnover exemption documents, Quality and technical compliance documents
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- Human Papilloma Virus Quadrivalent Vaccine (0.5ml, Types 6, 11, 16 & 18) — Qty: 30 unit
1 tender document(s) available — sign up to download.